188 related articles for article (PubMed ID: 15755545)
1. Tau phosphorylation increases in symptomatic mice overexpressing A30P alpha-synuclein.
Frasier M; Walzer M; McCarthy L; Magnuson D; Lee JM; Haas C; Kahle P; Wolozin B
Exp Neurol; 2005 Apr; 192(2):274-87. PubMed ID: 15755545
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial associated metabolic proteins are selectively oxidized in A30P alpha-synuclein transgenic mice--a model of familial Parkinson's disease.
Poon HF; Frasier M; Shreve N; Calabrese V; Wolozin B; Butterfield DA
Neurobiol Dis; 2005 Apr; 18(3):492-8. PubMed ID: 15755676
[TBL] [Abstract][Full Text] [Related]
3. Exacerbated synucleinopathy in mice expressing A53T SNCA on a Snca null background.
Cabin DE; Gispert-Sanchez S; Murphy D; Auburger G; Myers RR; Nussbaum RL
Neurobiol Aging; 2005 Jan; 26(1):25-35. PubMed ID: 15585343
[TBL] [Abstract][Full Text] [Related]
4. Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies.
Ferrer I; Blanco R; Carmona M; Puig B; Barrachina M; Gómez C; Ambrosio S
J Neural Transm (Vienna); 2001; 108(12):1383-96. PubMed ID: 11810403
[TBL] [Abstract][Full Text] [Related]
5. Fibrillization of alpha-synuclein and tau in familial Parkinson's disease caused by the A53T alpha-synuclein mutation.
Kotzbauer PT; Giasson BI; Kravitz AV; Golbe LI; Mark MH; Trojanowski JQ; Lee VM
Exp Neurol; 2004 Jun; 187(2):279-88. PubMed ID: 15144854
[TBL] [Abstract][Full Text] [Related]
6. Changes in adult olfactory bulb neurogenesis in mice expressing the A30P mutant form of alpha-synuclein.
Marxreiter F; Nuber S; Kandasamy M; Klucken J; Aigner R; Burgmayer R; Couillard-Despres S; Riess O; Winkler J; Winner B
Eur J Neurosci; 2009 Mar; 29(5):879-90. PubMed ID: 19291219
[TBL] [Abstract][Full Text] [Related]
7. Expression of stress-activated kinases c-Jun N-terminal kinase (SAPK/JNK-P) and p38 kinase (p38-P), and tau hyperphosphorylation in neurites surrounding betaA plaques in APP Tg2576 mice.
Puig B; Gómez-Isla T; Ribé E; Cuadrado M; Torrejón-Escribano B; Dalfó E; Ferrer I
Neuropathol Appl Neurobiol; 2004 Oct; 30(5):491-502. PubMed ID: 15488025
[TBL] [Abstract][Full Text] [Related]
8. The pattern of human tau phosphorylation is the result of priming and feedback events in primary hippocampal neurons.
Bertrand J; Plouffe V; Sénéchal P; Leclerc N
Neuroscience; 2010 Jun; 168(2):323-34. PubMed ID: 20394726
[TBL] [Abstract][Full Text] [Related]
9. Functional protein kinase arrays reveal inhibition of p-21-activated kinase 4 by alpha-synuclein oligomers.
Danzer KM; Schnack C; Sutcliffe A; Hengerer B; Gillardon F
J Neurochem; 2007 Dec; 103(6):2401-7. PubMed ID: 17883396
[TBL] [Abstract][Full Text] [Related]
10. Transduced wild-type but not P301S mutated human tau shows hyperphosphorylation in transgenic mice overexpressing A30P mutated human alpha-synuclein.
Oksman M; Wisman LA; Jiang H; Miettinen P; Kirik D; Tanila H
Neurodegener Dis; 2013; 12(2):91-102. PubMed ID: 22948283
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.
Yamada M; Iwatsubo T; Mizuno Y; Mochizuki H
J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678
[TBL] [Abstract][Full Text] [Related]
12. Trypsin disrupts the trafficking of the human dopamine transporter by alpha-synuclein and its A30P mutant.
Wersinger C; Vernier P; Sidhu A
Biochemistry; 2004 Feb; 43(5):1242-53. PubMed ID: 14756560
[TBL] [Abstract][Full Text] [Related]
13. Beta-amyloid overload does not directly correlate with SAPK/JNK activation and tau protein phosphorylation in the cerebellar cortex of Ts65Dn mice.
Lomoio S; Scherini E; Necchi D
Brain Res; 2009 Nov; 1297():198-206. PubMed ID: 19703431
[TBL] [Abstract][Full Text] [Related]
14. Aggregation of alpha-synuclein in the pathogenesis of Parkinson's disease.
Iwatsubo T
J Neurol; 2003 Oct; 250 Suppl 3():III11-4. PubMed ID: 14579119
[TBL] [Abstract][Full Text] [Related]
15. Aberrant expressions of pathogenic phenotype in Alzheimer's diseased transgenic mice carrying NSE-controlled APPsw.
Hwang DY; Cho JS; Lee SH; Chae KR; Lim HJ; Min SH; Seo SJ; Song YS; Song CW; Paik SG; Sheen YY; Kim YK
Exp Neurol; 2004 Mar; 186(1):20-32. PubMed ID: 14980807
[TBL] [Abstract][Full Text] [Related]
16. Initiation and synergistic fibrillization of tau and alpha-synuclein.
Giasson BI; Forman MS; Higuchi M; Golbe LI; Graves CL; Kotzbauer PT; Trojanowski JQ; Lee VM
Science; 2003 Apr; 300(5619):636-40. PubMed ID: 12714745
[TBL] [Abstract][Full Text] [Related]
17. Motor impairment and aberrant production of neurochemicals in human alpha-synuclein A30P+A53T transgenic mice with alpha-synuclein pathology.
Ikeda M; Kawarabayashi T; Harigaya Y; Sasaki A; Yamada S; Matsubara E; Murakami T; Tanaka Y; Kurata T; Wuhua X; Ueda K; Kuribara H; Ikarashi Y; Nakazato Y; Okamoto K; Abe K; Shoji M
Brain Res; 2009 Jan; 1250():232-41. PubMed ID: 18992718
[TBL] [Abstract][Full Text] [Related]
18. First appraisal of brain pathology owing to A30P mutant alpha-synuclein.
Seidel K; Schöls L; Nuber S; Petrasch-Parwez E; Gierga K; Wszolek Z; Dickson D; Gai WP; Bornemann A; Riess O; Rami A; Den Dunnen WF; Deller T; Rüb U; Krüger R
Ann Neurol; 2010 May; 67(5):684-9. PubMed ID: 20437567
[TBL] [Abstract][Full Text] [Related]
19. alpha-Synuclein and its disease-related mutants interact differentially with the microtubule protein tau and associate with the actin cytoskeleton.
Esposito A; Dohm CP; Kermer P; Bähr M; Wouters FS
Neurobiol Dis; 2007 Jun; 26(3):521-31. PubMed ID: 17408955
[TBL] [Abstract][Full Text] [Related]
20. The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy.
Höglinger GU; Lannuzel A; Khondiker ME; Michel PP; Duyckaerts C; Féger J; Champy P; Prigent A; Medja F; Lombes A; Oertel WH; Ruberg M; Hirsch EC
J Neurochem; 2005 Nov; 95(4):930-9. PubMed ID: 16219024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
